* That 'Jimmy-Table' Was Not Very Accurate * Cost Of Revenue & Income Were Much Worse * MJ Has An Entirely Different Hype Mechanism * And Of Course ... The OS Was Not Up To Date
RXMD Has A Bad Habit Of Always Trying To Associate Itself To Things That Don't Pertain , As Just A Way To Pander A Storyline & Illusion . Like: Marijuana, Bitcoin, Blockchain, Kioks, Amazon, CVC, Healthcare In General, Etc . They Talk "Everything" But Themselves .
Any Talk Of Up-Listing To Another Exchange Is So Far From Reality That Those Words Should Never Even Be Used In The Same Sentence As This Little Insignificant Meaningless Company .
All This Company Primarily Does Is To Put Pills In Little Plastic Containers, And To Then Deliver Them ... While Giving Required Consultations .
================================
FIRST HALF BIG NET LOSS
Always A Speculative Step Forward Then Three Fundamental Steps Back
FAILURE TO EXECUTE
H1-2016 Net Income = $217,765 Due To The One-&-Only Growth Spurt
H1-2017 Net Income = $25,144 Heading Back To Usual Net Losses
H1-2018 Net Loss = ($ TBA) Prepare For A Huge Net Loss !!!
WELCOME TO RXMD
Where Everything Is Always Speculative But Nothing Is Fundamentally Informative